Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Genetic factors influence growth and brain development in children.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Neural networks can effectively predict hair loss.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.